StonvexLoading…
StonvexStonvexStonvexCore line items from SRRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-102.02M | $-384.64M | $-292.75M | $-189.20M |
Net Income | $-105.51M | $-377.94M | $-286.97M | $-110.03M |
EPS (Diluted) | $-0.83 | $-3.29 | $-2.54 | $-1.65 |
Total Assets | $535.25M | $404.27M | $411.72M | $340.05M |
Total Liabilities | $259.24M | $158.78M | $166.72M | $106.75M |
Cash & Equivalents | $430.54M | $323.53M | $286.77M | $152.93M |
Free Cash Flow OCF − CapEx | $-82.17M | $-300.64M | $-225.11M | $-156.10M |
Shares Outstanding | 119.10M | 108.46M | 99.17M | 96.00M |